Mechelen, January 16th 2025 – Nipro PharmaPackaging and Nemera are pleased to announce the successful compatibility testing of Nemera’s UniSpray and Nipro’s unit-dose microvials. This collaboration aims to accelerate the time to market for combination products, particularly those used for rescue and crisis intervention.
Nemera’s UniSpray, a single-metered dose device for systemic drug administration, has been rigorously tested and proven fully compatible with Nipro’s unit-dose microvials. The comprehensive test program and assessment confirmed the combination product's reliability, safety, and performance, ensuring that UniSpray meets the required dose delivery and reliability standards thanks to its robust design.
“At Nemera, we design and manufacture devices that maximize treatment efficacy,” said Séverine Duband, Nemera’s Marketing Director for Devices. “We partner with our customers in the best possible way to ultimately bring patients high-quality and safe treatment solutions. Our work with primary drug packaging partners like Nipro further strengthens our commitment to bringing innovative combination products to customers and patients.”
For more information about UniSpray and our partners, visit:
https://www.nemera.net/products/ear-nose-throat/unispray/
Clément Condouret, Nipro PharmaPackaging Product Portfolio Manager for Nipro, said: “The high dimensional and cosmetic quality of Nipro unit-dose vials is crucial for ensuring optimal compatibility with Nemera’s UniSpray. This precision enhances the drug delivery system's reliability, safety, and performance, ultimately contributing to the efficacy and safety of patient treatments.”
For more information about Nipro Unit-dose microvials, visit:
https://www.nipro-group.com/en/our-offer/products-services/unit-dose-vials
Contact Nemera
Coraline Cortot - Global Communications Manager | +33 6 18 78 27 74 |
[email protected]
Contact Nipro
Annick Somers - Chief Marketing Officer | Marketing & PR – General | +32 15 26 35 54 | [email protected]
About Nemera
As a world-leading drug delivery device solutions and combination product services partner, Nemera’s purpose of putting patients first enables the design and manufacture of devices that maximize treatment efficacy. Nemera is committed to the highest quality standards, from early device strategy to state-of-the-art manufacturing. Agile and open-minded, Nemera works closely with customers to ensure the success of their combination products. For more information, visit: www.nemera.net
About Nipro
Nipro PharmaPackaging specializes in developing and manufacturing advanced pharma packaging products and complete packaging solutions for early development drugs or enhancing packaging solutions for existing drugs. Nipro strives to be the preferred and trusted partner of pharmaceutical companies around the globe in safely delivering parenteral medicines to patients.
Nipro PharmaPackaging is part of Nipro Corporation Japan, established in 1954. As a leading global healthcare company with over 38,000+ employees worldwide, Nipro serves the Pharmaceutical, Medical Device, and Pharmaceutical Packaging industries. For more information, visit: www.nipro-group.com
